Council of Scientific and Industrial Research patents nigericin derivatives March 15, 2022 No Comments
1st Bio Therapeutics identifies new ABL/LRRK2/LRRK2 mutant/RIPK2 inhibitors March 15, 2022 No Comments
Bright Minds' BMB-101 for Dravet syndrome completes 28-day repeat toxicity studies March 14, 2022 No Comments
Del-1 potentiates BCI efficacy by blockade of tumor-infiltrating neutrophils March 14, 2022 No Comments
Discovery of novel MDM2 inhibitor with antitumor activity in p53 wild-type cancer models March 14, 2022 No Comments